insights on Bioecon

Bioeconomy trends: where biology is replacing chemistry

Mon, 01 Jan 0001 00:00:00 +0000

Big trends: replacing dangerous chemicals with bioeconomy solutions

This is an overview of the article collections in this vault. Each collection covers a sector where hazardous chemicals are still widely used and matches them with alternatives that are already proven in practice: microbes, enzymes, vaccines, beneficial organisms, bio-based materials, fermentation products, genetics and ecological management. Every article has the same structure: the chemical problem → the alternative → composition → key facts → advantages → mode of action → application → limitations → peer-reviewed evidence → bioeconomy value. Each folder also has a README index with a “skipped” list for hazards that have no proven biological substitute yet.

Business models: Novonesis as the role model, 37 peers

Mon, 01 Jan 0001 00:00:00 +0000

Business models of mature bioeconomy companies — Novozymes / Novonesis as the role model

38 companies · 265 verified facts. Articles now carry an Industry pioneers section linking these companies to the substitutions they commercialised (tools/company_sections.py).

The role model: what Novozymes / Novonesis actually sells#

Novonesis (Novozymes + Chr. Hansen, merged 29 January 2024) does not sell “biology”. It sells performance inside someone else’s factory: an enzyme, culture or microbe that a detergent maker, starch plant, ethanol plant, dairy, bakery, feed mill or farmer drops into an existing process to get the same output with less chemical, energy or raw material. The verified facts behind that model (profiles below):

Demand signals: tenders and grants by industry

Mon, 01 Jan 0001 00:00:00 +0000

Demand signals — live tenders and grants matched to our supplier index

Territory: Russia / EAEU (owner decision 2026-10-06). In-territory demand = 1 tender(s): 44-FZ — Procurement of 2000L bioreactors ($800K). The other 2 tenders and all 46 grant calls are outside Russia/EAEU (EU TED, US SAM.gov, EC/CBE JU/UKRI/NSF grants) and are kept below only as market context. This snapshot has no zakupki.gov.ru capture yet — a direct 44-FZ/223-FZ capture is the missing demand source.

Ecosystem catalogue

Mon, 01 Jan 0001 00:00:00 +0000

Bioeconomy ecosystem catalogue — 635 technologies in 46 clusters

captures in asia_biotech_research/data/bioecon/ (technology index captured 2026-09-29).

This is the commercial view of the ecosystem: every technology, who supplies it, how crowded and how risky it is, where it is active, whether we have read the dossier, and whether our own vendor index can already name a supplier. TECH-STACK-MAP.md remains the record of what we changed in our own tagging; this catalogue does not replace it.

Evidence: how bio-practices displace old processes

Mon, 01 Jan 0001 00:00:00 +0000

Disruption evidence — has the bio-based practice actually displaced the old process?

Grades (from verified claims only): D3 proven displacement at scale — a majority share or a large measured reduction of the old process, measured nationally or wider, from a peer-reviewed, government/intergovernmental or industry-association source · D2 measurable displacement — a strong-source displacement figure at a smaller scale (minority share, or a city/district programme) · D1 works, but displacement not shown (only performance, cost, trial-area or weak-source figures) · D0 no verified evidence.

Government funding signals behind bio-alternatives

Mon, 01 Jan 0001 00:00:00 +0000

Government funding signals: which bioeconomy alternatives governments actually fund

Idea: public research and innovation grants for a specific product or technology are one of the best leading indicators that it is real, needed and close to adoption. Governments fund what regulators want to replace and what industry is ready to take up. Every article in this vault now has a “Government funding signals” section. This page ranks all 90 alternatives of the first wave, plus the 8 second-wave articles at the end.

Market map: Africa Middle East non-medical biotech

Mon, 01 Jan 0001 00:00:00 +0000

Africa & Middle East Non-Medical Biotech — Market Map (DRAFT, September 2026)

Scope: industrial biotech & bio-based materials, agricultural biotech & AgTech, food biotech, environmental & marine biotech, plus bioenergy, forestry and restoration. Pharma, diagnostics, devices and veterinary medicines are excluded.

Region: all of Africa and the Middle East (Gulf, Levant, Iraq, Iran, Turkey, Yemen). Cyprus is out. Scope decisions (carried over from the Americas dataset, owner 2026-09-25):

Local subsidiaries of groups from outside the region (e.g. Hazera/Limagrain, Netafim/Orbia, Adama/Syngenta, Illovo/ABF, Real IPM/Certis Belchim, Algatech/Solabia) are excluded.
Region-origin companies headquartered abroad (common for Israeli companies) are kept, filed under the home country.
No country may exceed 40 % of the dataset (COUNTRY_CAP = {"*": 0.40}, applied to discovery).
Public research bodies and international research centres (Volcani, KALRO, ARC, IITA, ILRI, ICIPE, ICBA …) are included. Universities and associations are not.
Countries under broad sanctions regimes (Iran, Syria, Sudan …) are included but marked † (informational).

Status: drafted from model knowledge, then vetted with check-map (2026-09-25); 1 foreign-owned entry removed (see bottom).

Market map: Americas non-medical biotech

Mon, 01 Jan 0001 00:00:00 +0000

Latin America & Caribbean Non-Medical Biotech — Market Map (DRAFT, September 2026)

Region: the Americas without the USA and Canada (Puerto Rico and other US territories are out too). Scope decisions (owner, 2026-09-25):

Local subsidiaries of non-Latin-American multinationals (Cargill Brasil, Corteva Argentina, Novonesis Brasil …) are excluded.
Latin American-origin companies headquartered in the US (or elsewhere) are kept, filed under their Latin American country.
Brazil is capped at 40 % of the dataset (COUNTRY_CAP in exa_osint.py, applied to discovery).
Public research bodies (Embrapa, INTA, INIA, CIMMYT …) are included. Universities and associations are not.

Status: drafted from model knowledge, then vetted with check-map (2026-09-25): 5 foreign-owned entries removed (see bottom). URLs, tickers and ownership may be wrong or out of date. Run python3 exa_osint.py check-map --max-usd 1 and fix this file before running research. The list is a seed only: asia-seed + discover add companies similar to the Asia dataset and to these seeds.

Market map: Asia non-medical biotech

Mon, 01 Jan 0001 00:00:00 +0000

Asia Non-Medical Biotech — Market Map (as of September 2026)

Scope: industrial biotech & bio-based materials (1), agricultural biotech & AgTech (2), food biotech (3), environmental & marine biotech (4). Pharma/drugs/diagnostics/devices excluded. All URLs live-checked Sept 2026 (see Method note at bottom).

Revision note (follow-on pass): Taiwan section completed (was pending); ~48 additional companies added across existing country/category tables where cross-checked against a parallel compilation; five supplementary bioeconomy verticals appended at the end (Animal & Aquaculture Biotech, Biotech-Derived Textiles & Materials, Biotech-Derived Cosmetic & Personal-Care Ingredients, Genome & Epigenome Editing [ag/industrial only], Carbon Markets & Ecosystem Restoration). New additions were NOT independently live-URL-verified to the original Sept 2026 standard — cross-check before relying on them for outreach or diligence.

Merge note: this file consolidates the source-verified market map above with the earlier chat-session working draft (four remaining China industrial-biotech entries — Zhejiang Huafon Biomaterials, Zhejiang NHU Company, Shandong Bailong Chuangyuan, Shandong Landian Biological Technology — were the only unique companies not already present here). The standalone working draft and its “README_updated.md” duplicate have been retired in favor of this single file.

Market map: Eu Gb non-medical biotech

Mon, 01 Jan 0001 00:00:00 +0000

Europe (EU, UK, Switzerland, non-EU Europe) non-medical biotech — seed market map (DRAFT, unverified)

Drafted 2026-10-05 by an agent to seed the eu_gb_biotech_research dataset. Gap-led: most companies were chosen because they supply products that the vault’s articles need but the Africa/ME, LatAm, Asia and USA & Canada datasets lack (codes in brackets refer to articles with an “Honest finding” gap note), or because they lead a vault rubric. Names, URLs, ownership and status are NOT verified here. exa_osint.py check-map (vetting) and status verify every row, and the pipeline finds URLs left as N/A. Scope rules: see ../AGENTS.md. check-map 2026-10-05 removed Meatable (winding down), Verdera (owned by Lallemand, Canada), Biofa (Andermatt subsidiary) and ThermoSeed (Lantmännen subsidiary); the parents stay in the map.

Market map: Usa Canada non-medical biotech

Mon, 01 Jan 0001 00:00:00 +0000

USA & Canada non-medical biotech — seed market map (DRAFT, unverified)

Drafted 2026-10-02 by an agent to seed the usa_canada_biotech_research dataset. Gap-led: companies were chosen because they supply products the vault’s articles need but its Africa/ME, LatAm and Asia datasets lack (struvite, enteric-methane additives, bio-cement, bioleaching, Wolbachia, bio-deicers, fermentation equipment) or because they lead a vault rubric. Names, URLs and status are NOT verified here — exa_osint.py check-map (vetting) and status verify every row; URLs left N/A are found by the pipeline. Scope rules: see ../AGENTS.md. check-map 2026-10-02 removed AEF Global (owned by Sumitomo, Japan) and Enterra Feed (receivership 2022).

Market size of bio-alternatives

Mon, 01 Jan 0001 00:00:00 +0000

Market size — the missing commercial layer

Curated 2026-09-30 by agent research (public web), extended same day with a second retrieval pass. Not generated — each figure was hand-sourced and must be re-verified before commercial use. Scope: the top 20 articles by regulatory pressure (bans/withdrawals/authority mentions weighted 3:2:1), as ranked from the article texts.

Purpose: answer “what is the prize?” for each substitution — the incumbent chemical’s market (what is being replaced) and the bio-alternative’s market (where the agency plays).

Reference verification report

Mon, 01 Jan 0001 00:00:00 +0000

Reference verification report

Every reference in the 90 articles was checked automatically against Crossref (free public API) and, where Crossref was silent, PubMed. For each one the title, year, first author, volume and pages were compared with the best match, and every problem case was then checked by hand. Run date: 2026-09-27.

Result: 286 verified · 3 unverified (older journal volumes not indexed) · 44 regulations/books/reports not checkable in Crossref. The total is 333 references.

Technology stack map

Mon, 01 Jan 0001 00:00:00 +0000

Tech stack map - our project vs the bioecon.ru technology index

Companion document: ECOSYSTEM-CATALOGUE.md (generated by tools/build_ecosystem_catalogue.py) covers all 635 technologies in 46 clusters as a commercial ecosystem — per-technology supplier counts, risk, regions, dossier status and our own links — and lists the enrichment backlog including the deferred watchlist below. This map stays the record of what we changed in our own tagging; the catalogue is the wider view.

Written 2026-09-29. Source: en.bioecon.ru/technology (635 technology dossiers). Raw captures in asia_biotech_research/data/bioecon/: technologies.json (full index), tech_pages.json (91 vault-relevant dossier texts), tech_suppliers.json (parsed supplier tables), tech_coverage_review.json (this review, machine-readable), TECH-STACK-CHECK-2026-09-29.html (the first check report).

Where we are looking for suppliers

Mon, 01 Jan 0001 00:00:00 +0000

Rubric gaps — review and third-wave decision (2026-10-01)

Hand-written record (not generated). Owner approval: “add all. approved” (2026-10-01).

What was reviewed#

The vault had 17 rubrics (121 articles), all built on one frame: a hazardous chemical → a proven biological alternative. The review compared that taxonomy with the vendor index (1,816 companies) and with the standard scope of the bioeconomy, using:

index topic tags on the 172 companies that had no rubric — dominated by seeds-breeding, sugar-palm-agri-processing, cea-vertical-farming, agtech-digital, plant-based, cultivated-meat, gm-gene-editing;
keyword counts over company cards for candidate themes (rough; candidates only, not verified);
the vault’s own trends (BIOECONOMY-TRENDS.md): trend 1 “host immunity and genetics” and trend 2 “diagnose → threshold → treat” had no collection of their own.

Decision: 9 new collections + 2 food-ingredient articles (26 articles)#

Collection	Articles	Why it was missing	Supply in the index
`fertilizers-nutrition/`	NU01–NU04	Crop nutrition had only A35/A36, though SoyuzAgroHim is a fertilizer catalogue and mineral N is the largest agrochemical by volume	Strong (biostimulants, inoculants, organo-mineral); struvite: gap
`seeds-genetics/`	SG01–SG04	Trend 1 had no rubric; the largest group of companies with no rubric	Strong for crop seed and shrimp genetics; resistant livestock lines: gap
`waste-circular/`	WC01–WC03	Residue burning, food waste and sludge had no home (energy covered only the gas)	Strong
`remediation/`	RM01–RM03	Ecology covered only marine oil spills	Strong (hydrocarbons, biofilters); phytoremediation contractors: gap
`livestock-emissions/`	LE01–LE02	Strong regulatory pull (Denmark livestock tax, EU IED), nothing in the vault	Enteric methane additives: gap; manure digestion present
`diagnostics/`	DX01–DX02	Trend 2 had no rubric	Moderate
`alt-proteins/`	AP01–AP02	Outside the strict chemical frame — added by owner decision; ratings Partial/Watchlist	Strong
`cea-horticulture/`	CE01–CE02	Peat and post-methyl-bromide fumigants not covered	Moderate; peat-free substrates thin
`biorefining/`	BR01–BR02	Sugar/palm mills and platform chemicals had no home	Strong
`food-ingredients/` (existing)	FI07–FI08	Processing aids (bromate/ADA, chemical oil refining) fit the frame exactly	FI07 strong; FI08 two suppliers, lipase gap

Deliberately not added#

Human biopharma and human diagnostics — out of scope for the whole vault.
Seaweed and algae as a rubric — they are a feedstock used across many rubrics (FI06, NU01, LE01, cosmetics, feed), so they are better treated as a topic running through those rubrics.
Herbicide-tolerant crops — a genetic trait that enables herbicide use rather than replacing it (see the seeds-genetics skipped list).

Method used (same rules as the earlier waves)#

Every cited supplier was checked against its own card text (Focus / Profile / official website, via tools/rubrics.card_text) and is active. Where nothing qualified, the article carries an Honest finding gap note instead of a padded table (NU04, LE01, RM02, CE01, FI08 partly, SG03 partly).
All 95 planned journal references were checked against Crossref before writing (90 matched automatically; 1 is classed as a report only because the author name starts lower-case — du Jardin; 3 confirmed by direct DOI lookup and added to tools/hand-verified.json; 1 that could not be found in Crossref was dropped). Nightly ref_verify after the build: 439 verified / 0 check.
Government funding signals: tools/grants_scan.py (OpenAIRE + NSF, free), candidates reviewed by hand, 2026-10-01.
No paid API calls were made.

Tooling changes#

tools/rubrics.py: 9 new rubric rules (topic tags + product-specific keywords; generic words such as “fertilizer”, “methane”, “greenhouse” deliberately excluded so incumbent-chemistry makers are not pulled in).
Collection lists extended in index_check.py, ref_verify.py, supplier_index.py, build_dashboard.py, build_priority_board.py, sellable_now.py.

Supplier gaps worth a targeted `rubric-seed` pass (paid; owner-gated)#

Enteric-methane feed additives and Asparagopsis growers (LE01).
Struvite / recovered-phosphate producers and licensees (NU04).
Phytoremediation and mine-rehabilitation contractors (RM02).
Coir, wood-fibre and bark substrate makers (CE01).
Immobilized-lipase suppliers for oil interesterification (FI08).

Follow-up 2026-10-01/02: targeted supplier passes (paid, owner-approved “do all”)#

RUBRIC_SECTORS gained 5 sectors in all three datasets (methane-feed, struvite, phytoremediation, growing-media, lipase-oils); the BIO pre-filter and the vetting scope text were widened to match.
rubric-seed: 13 + 22 + 40 countries × 5 new sectors, $2.71, 0 errors.
Gap-only discover (only the 5 new seed sets fed the pool; wrapper kept in the session scratchpad): vetted the top 150/150/200 candidates, 178 new companies accepted (Asia 75, LatAm 54, Africa & ME 49) → index 1,816 → 1,994. Research + status top-up: $10.00 + $7.01. Every new company has a status check; 73 still have one or more research steps incomplete (budget stop) — a later research/discover run fills them from cache at low cost.
Results per gap:
- CE01 peat-free media — closed: 14 coir/coco-substrate makers now cited (Sri Lanka, India, Bangladesh, Peru, Mexico).
- RM02 phytoremediation — partly closed: 4 mine-rehabilitation/revegetation contractors + 1 public agency cited; no metal phytoextraction supplier.
- NU04 struvite, LE01 enteric-methane additives, FI08 enzymatic interesterification — still no qualifying supplier; these look like genuine regional gaps (the technology vendors sit in Europe, North America, Australia, Japan).
For the owner (removal is an owner decision, nothing was deleted): vetting accepted some doubtful companies from the lipase-oils and phytoremediation seeds — e.g. edible-oil mills (Golden Oil Industries, Vester Oil Mills, United Oil Company, Iran Oil Products Company), and Kenana Engineering (Sudan) whose URL is a redirect link. Giloil Company Ltd (Kenya) now has two cards (giloil-company-ltd and giloil-company-ltd-2). Use sources/overrides.json exclude if you want any of them out.
Bug found and fixed: re-selecting an already-discovered company overwrote its hand-fixed Latin name with the raw Exa name, so two companies fell back to the degenerate id company. Fixed in discover() (all three datasets: a re-selected company keeps its existing name and aliases); Kubota Environmental Service, NCVC and the new Shandong Chuangxin Humic Acid Technology were given Latin names, reusing their caches.

Addendum 2026-10-02: rubrics derived from the bioecon.ru taxonomy comparison#

Compared the vault’s 26 rubrics with the bioecon.ru cluster spine (11 sectors → 46 clusters, hugo_skill/data/clusters.yaml) and with the companies still lacking a rubric. Result:

insights on Bioecon

Bioeconomy trends: where biology is replacing chemistry

Big trends: replacing dangerous chemicals with bioeconomy solutions

Business models: Novonesis as the role model, 37 peers

Business models of mature bioeconomy companies — Novozymes / Novonesis as the role model

The role model: what Novozymes / Novonesis actually sells#

Demand signals: tenders and grants by industry

Demand signals — live tenders and grants matched to our supplier index

Ecosystem catalogue

Bioeconomy ecosystem catalogue — 635 technologies in 46 clusters

Evidence: how bio-practices displace old processes

Disruption evidence — has the bio-based practice actually displaced the old process?

Government funding signals behind bio-alternatives

Government funding signals: which bioeconomy alternatives governments actually fund

Market map: Africa Middle East non-medical biotech

Africa & Middle East Non-Medical Biotech — Market Map (DRAFT, September 2026)

Market map: Americas non-medical biotech

Latin America & Caribbean Non-Medical Biotech — Market Map (DRAFT, September 2026)

Market map: Asia non-medical biotech

Asia Non-Medical Biotech — Market Map (as of September 2026)

Market map: Eu Gb non-medical biotech

Europe (EU, UK, Switzerland, non-EU Europe) non-medical biotech — seed market map (DRAFT, unverified)

Market map: Usa Canada non-medical biotech

USA & Canada non-medical biotech — seed market map (DRAFT, unverified)

Market size of bio-alternatives

Market size — the missing commercial layer

Reference verification report

Reference verification report

Technology stack map

Tech stack map - our project vs the bioecon.ru technology index

Where we are looking for suppliers

Rubric gaps — review and third-wave decision (2026-10-01)

What was reviewed#

Decision: 9 new collections + 2 food-ingredient articles (26 articles)#

Deliberately not added#

Method used (same rules as the earlier waves)#

Tooling changes#

Supplier gaps worth a targeted rubric-seed pass (paid; owner-gated)#

Follow-up 2026-10-01/02: targeted supplier passes (paid, owner-approved “do all”)#

Addendum 2026-10-02: rubrics derived from the bioecon.ru taxonomy comparison#

Supplier gaps worth a targeted `rubric-seed` pass (paid; owner-gated)#